A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2506068
The present invention concerns pharmaceutical compositions containing one of the receptors FcyR IIb or FcyR III in a recombinantly produced, soluble form and their use to treat diseases or conditions which are caused by overshooting immune reactions and a pathologically increased formation of antibodies, in particular of autoantibodies. Multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis are particularly important fields of application.
La présente invention concerne des compositions pharmaceutiques contenant le récepteur FcyR llb ou le récepteur FcyR III sous une forme soluble et produit recombinant, et leur utilisation pour traiter des maladies ou des états dus à des réactions immunitaires exubérantes et à la formation accrue d'anticorps, notamment d'auto-anticorps. Ces compositions pharmaceutiques sont particulièrement utiles dans les domaines d'application suivants : scléose multiple, lupus érythémateux général et polyarthrite rhumatoïde.
Huber Robert
Jacob Uwe
Sondermann Peter
Max-Planck Gesellschaft Zur Foerderung Der Wissenschaften E.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Pharmaceutical composition containing sfcyr iib or sfcyr iii does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing sfcyr iib or sfcyr iii, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing sfcyr iib or sfcyr iii will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1942900